Autres langues Sun Pharmaceutical Industries Ltd.

Actions

SUNPHARMA

INE044A01036

Produits pharmaceutiques

Marché Fermé - NSE India S.E. 13:05:10 01/10/2026			Varia. 5j.	Varia. 1 janv.
1 801,00 ^INR	-0,86%		-3,43%	+4,73%

30/09	Pharmazz, Inc. obtient de la FDA américaine l’autorisation IND de lancer un essai clinique de phase 3 du sovateltide dans les traumatismes crâniens	CI
30/09	Sun Pharma prévoit de lever 1,04 milliard de dollars via des obligations en roupies pour refinancer son prêt relais auprès d’Organon	MT

Autres langues

30/09	Pharmazz, Inc. Receives U.S. FDA IND Clearance To Initiate Phase 3 Clinical Trial Of Sovateltide In Traumatic Brain Injury
30/09	Sun Pharma Plans $1.04 Billion via Rupee Bonds to Refinance Organon Bridge Loan
30/09	Mayne Pharma Group Settles Patent Litigation With Sun Pharmaceutical Industries
29/09	India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
28/09	LIB Therapeutics Inc. And Sun Pharmaceutical Industries Limited Announce Global Licensing, Commercialization And Manufacturing Agreement For Lerodalcibep, A Novel PCSK9 Inhibitor, Ex-US And China
28/09	Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
28/09	Sun Pharma Gets Rights to Commercialize Cholesterol Drug Outside US, China
24/09	Sun Pharmaceutical Industries Limited Launches Taro-Methylphenidate ER In Ontario And Quebec
24/09	Sun Pharma Launches (C)Taro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System
09/09	Sun Pharma Sets Up Global Treasury Center in India's GIFT City
09/09	Sun Pharma Assigned Baa1, BBB+ Ratings by Moody's, S&P
01/09	Global pharma companies that have publicly announced Trump drug pricing agreements
31/08	Trump announces new round of drug-pricing deals
05/08	CRISIL Keeps AAA Rating on Sun Pharmaceutical's Bank Facilities
31/07	Sun Pharmaceutical's Consolidated Net Profit Grows in Fiscal Q1
31/07	Sun Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
31/07	Sun Pharma's quarterly profit jumps on strength in specialty medicines
30/07	Sun Pharma Gets Brazil Approval for Semaglutide Injection
29/07	Sun Pharmaceutical Industries Limited Receives Approval to Manufacture and Market Semaglutide in Brazil
22/07	Trump will Generika-Produktion mit massiven Zöllen in die USA zwingen
21/07	South Africa regulator reviews 12 generic semaglutide applications
15/07	India's Sun Pharma wins South Africa approval to launch generic Ozempic
15/07	Sun Pharma Wins South Africa Approval for Generic Semaglutide
15/07	Sun Pharmaceutical Industries Limited Receives Approval to Manufacture and Market Generic Semaglutide in South Africa
10/07	India's Dr Reddy's posts worst week in 3 years as semaglutide setback stokes growth fears